Oslo, 27 April 2017: Photocure ASA (OSE: PHO), held its annual general meeting on 27 April 2017 at 17:00 hours (CET).
All proposals were resolved as presented in the notice convening the general meeting dated 5 April 2016, as further set out in the minutes from the general meeting attached hereto.
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000, Email: ed@photocure.no
About Photocure ASA
Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company and world leader in photodynamic technology. As a commercial stage company focused on the urology market, Photocure's proprietary technology provides improved detection and management of bladder cancer. Our aim is to provide solutions which can improve health outcomes for patients worldwide. Photocure is listed on the Oslo Stock Exchange (OSE: PHO). Information about Photocure is available at www.photocure.com.
